NovoCure Limited (NVCR)

NovoCure Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-170.95	-168.63	-207.04	-92.53	-58.35	19.81
Depreciation & Amortization	10.96	9.87	9.7	9.57	9.17	7.75
Other Amortization	5.14	5.14	4.59	4.35	4.42	5.91
Asset Writedown & Restructuring Costs	3.51	1.16	0.49	0.96	0.65	0.43
Loss (Gain) From Sale of Investments	-28.27	-28.27	-26.4	-4.83	-0.24	-1.25
Stock-Based Compensation	149.82	160.04	115.61	106.96	94.9	75.72
Other Operating Activities	-0.47	-2.02	0.07	-5.47	3.14	-0.7
Change in Accounts Receivable	-31.02	-26.36	29.41	2.55	5.27	-30.35
Change in Inventory	0.76	2.57	-8.92	-4.34	2.48	-2.94
Change in Accounts Payable	13.49	19.11	14.87	14.26	27.78	25.47
Change in Other Net Operating Assets	2.36	1.04	-5.71	-0.67	-6.46	-0.7
Operating Cash Flow	-44.68	-26.37	-73.34	30.79	82.76	99.15
Operating Cash Flow Growth	-	-	-	-62.80%	-16.53%	272.46%
Capital Expenditures	-35.72	-42.86	-27.09	-21.36	-24.17	-14.97
Investment in Securities	53.22	-97.39	211.24	-118.6	-120.66	-457.88
Investing Cash Flow	17.5	-140.24	184.15	-139.96	-144.83	-472.85
Long-Term Debt Issued	-	96.92	-	-	-	558.44
Long-Term Debt Repaid	-	-12.91	-0.01	-0.03	-0.03	-150.03
Net Debt Issued (Repaid)	-	84.01	-0.01	-0.03	-0.03	408.41
Issuance of Common Stock	10.42	6.31	15.8	15.52	25.73	31.8
Financing Cash Flow	10.42	90.32	15.79	15.49	25.7	440.21
Foreign Exchange Rate Adjustments	0.45	-0.17	0.13	-0.1	-0.19	0.25
Net Cash Flow	-16.31	-76.47	126.73	-93.78	-36.56	66.76
Free Cash Flow	-80.4	-69.22	-100.43	9.43	58.59	84.18
Free Cash Flow Growth	-	-	-	-83.90%	-30.40%	421.72%
Free Cash Flow Margin	-12.76%	-11.44%	-19.72%	1.75%	10.95%	17.03%
Free Cash Flow Per Share	-0.73	-0.64	-0.94	0.09	0.57	0.77
Cash Interest Paid	11.06	7.71	0.01	0.04	0.1	8.69
Cash Income Tax Paid	31.86	23.46	13.67	5.48	3.11	-3.26
Levered Free Cash Flow	5.94	9.29	-1.98	51.76	104.89	66.98
Unlevered Free Cash Flow	10.83	11.99	-3.21	50.55	103.7	73.45
Change in Net Working Capital	9.46	11.72	-38.65	-9.9	-50.03	15.71

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q